2009
DOI: 10.1016/s0181-5512(09)73705-2
|View full text |Cite
|
Sign up to set email alerts
|

581 Une nouvelle ciclosporine A 1 % et 2 % : toxicité, tolérance et observance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Intolerance has been addressed in previous studies on topical CSA because it can hinder its effectiveness. 3,23–25 Jeng and Holsclaw 4 reported the absence of intolerance in their CSA-treated group. Conversely, other authors noted moderate to severe intolerance to CSA in 7% to 25% of patients.…”
Section: Discussionmentioning
confidence: 99%
“…Intolerance has been addressed in previous studies on topical CSA because it can hinder its effectiveness. 3,23–25 Jeng and Holsclaw 4 reported the absence of intolerance in their CSA-treated group. Conversely, other authors noted moderate to severe intolerance to CSA in 7% to 25% of patients.…”
Section: Discussionmentioning
confidence: 99%